Toddler obesity study pulled before it even started

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults * Self-identify as being of Hispanic/Latino or African American ethnicity * BMI ≥30 with a stable weight (no more than 5% variation during the previous 3 months) and an agreement not to initiate any other weight loss * HbAlc ≤ 6.4 * Fluent in written and spoken English Exclusion Criteria: Adult * Current cancer treatment * Have been treated with prescription drugs that promote weight loss (for example, liraglutide \[Saxenda™\], orlistat \[Xenical®\], phentermine Adipex®\], phentermine/topiramate \[Qsymia™\], semaglutide 2.4 mg \[Wegovy™\], tirzepatide \[Zepbound™\], bupropion/naltrexone \[Contrave™\], phentermine \[Lomaira™\] or similar other weight loss medications including over-the-counter (OTC) medications (for example, Alli®). Use of obesogenic medications (including but not limited to steroids, haloperidol, clozapine, risperidone, olanzapine, amitriptyline, imipramine, paroxetine, and lithium) which cannot be substituted or stopped * History of drug or alcohol abuse * Nursing or planning to become pregnant in the next 10 months * Unwilling to use accepted standards of birth control if female and before menopause age. (i.e. IUD, birth control pills/injections, tubal or vas deferens ligation) during the study and for 30 days after the study is completed. Condoms or rhythm methods are not sufficient. Inclusion Criteria: (Toddler) * Self-identify as being of Hispanic/Latino or African American ethnicity * BMI ≥ 95th percentile for age, gender and height * Age 12 to 36 months of age * Spends at least half of its awake time per day with the P/OCG who is the consenting adult and who provides at least half of the toddler's diet on that day Exclusion Criteria (Toddler) * Current cancer treatment * Use of obesogenic medications (including but not limited to steroids, haloperidol, clozapine, risperidone, olanzapine, amitriptyline, imipramine, paroxetine, and lithium) which cannot be substituted or stopped * Genetic disorders and/or physical or mental handicaps that would limit participation in the study and/or the lifestyle intervention * Any special dietary or exercise requirements * Any established chromosome abnormalities that might be associated with obesity